Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

May 14, 2019

Industry Trends in China: The Generic Consistency Evaluation

In China, the industrial and regulatory landscape has been evolving rapidly – and in particular as it relates to generic drug products. In 2015, the China State Council announced Opinions on Reforming the Review and Approval System for Drugs and Medical Devices (No. 44). At this same time, a series of reforms were announced by the National Drug Administration of China (formerly the China Food and Drug Administration, CFDA) to upgrade the pharmaceutical industry by raising marketed products to international standards in terms of quality, safety and efficacy.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Previous Posts
SmartDose Platform

April 26, 2019

Overcoming Challenges Associated with Biologic Drug Formulation and Development

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

What's New In the West Knowledge Center

April 16, 2019

What’s New in the Knowledge Center?

Tara Haarlander

Tara Haarlander

Sr. Specialist, Scientific Communications

West Employee standing in front of the West logo sign

July 05, 2018

West Corporate Responsibility Report: Compliance and Ethics

Jenn Zerbe

Jennifer Zerbe

Senior Specialist, Corporate Communications

Lab Testing

September 05, 2017

Spotlight on West’s Health and Safety Programs

Elizabeth Crawford

Elizabeth Crawford

Exton Communications Team Intern

integrity logo

June 29, 2017

West Reports on Corporate Responsibility for 2016

Elizabeth Crawford

Elizabeth Crawford

Exton Communications Team Intern


April 28, 2017

Future Readiness - Compliance with New USP Chapter <382>

Daniel Bantz

Daniel Bantz

Tech Manager, Packaging & Performance, Laboratory

Load more